Issue Date | Title | Author(s) |
2019-04-01 | Electrically conductive nanomaterials for cardiac tissue engineering | Ashtari, K; Nazari, H; Ko, H; Tebon, P; Akhshik, M; Akbari, M; Alhosseini, SN; Mozafari, M; Mehravi, B; Soleimani, M; Ardehali, R; Ebrahimi Warkiani, M; Ahadian, S; Khademhosseini, A |
2021-01-15 | Advances of microfluidic technology in reproductive biology. | Nikshad, A; Aghlmandi, A; Safaralizadeh, R; Aghebati-Maleki, L; Warkiani, ME; Khiavi, FM; Yousefi, M |
2021-03-01 | Development and in vitro characterization of a novel pMDI diclofenac formulation as an inhalable anti-inflammatory therapy for cystic fibrosis. | Sheikh, Z; Gomes Dos Reis, L; Bradbury, P; Meneguzzo, G; Scalia, S; Young, PM; Ong, HX; Traini, D |
2021-07-05 | Tobramycin and Colistin display anti-inflammatory properties in CuFi-1 cystic fibrosis cell line. | Sheikh, Z; Bradbury, P; Reekie, TA; Pozzoli, M; Robinson, PD; Kassiou, M; Young, PM; Ong, HX; Traini, D |
2020-10 | β-radiating radionuclides in cancer treatment, novel insight into promising approach. | Asadian, S; Mirzaei, H; Kalantari, BA; Davarpanah, MR; Mohamadi, M; Shpichka, A; Nasehi, L; Es, HA; Timashev, P; Najimi, M; Gheibi, N; Hassan, M; Vosough, M |
2016 | Stabilization of Paclitaxel-Conjugated Micelles by Cross-Linking with Cystamine Compromises the Antitumor Effects against Two- and Three-Dimensional Tumor Cellular Models | Du, AW; Lu, HX; Stenzel, M |
2020-11 | An in vitro model for assessing drug transport in cystic fibrosis treatment: Characterisation of the CuFi-1 cell line. | Sheikh, Z; Bradbury, P; Pozzoli, M; Young, PM; Ong, HX; Traini, D |
2018-03-01 | Curcumin-lipoic acid conjugate as a promising anticancer agent on the surface of gold‑iron oxide nanocomposites: A pH-sensitive targeted drug delivery system for brain cancer theranostics | Ghorbani, M; Bigdeli, B; Jalili-baleh, L; Baharifar, H; Akrami, M; Dehghani, S; Goliaei, B; Amani, A; Lotfabadi, A; Rashedi, H; Haririan, I; Alam, NR; Hamedani, MP; Khoobi, M |
2020-07-01 | Kinetic and thermodynamic study of c-Met interaction with single chain fragment variable (scFv) antibodies using phage based surface plasmon resonance. | Ghorbani, F; Fathi, F; Aghebati-Maleki, L; Abolhasan, R; Rikhtegar, R; Dolatabadi, JEN; Babaloo, Z; Khalilzadeh, B; Warkiani, ME; Sharifzadeh, Z; Rashidi, M-R; Yousefi, M |
2021-04 | Novel molecular targets in gastric adenocarcinoma. | Ramezankhani, R; Solhi, R; Es, HA; Vosough, M; Hassan, M |